Invention Grant
- Patent Title: Methods for treating active eosinophilic esophagitis
-
Application No.: US16054583Application Date: 2018-08-03
-
Publication No.: US11053309B2Publication Date: 2021-07-06
- Inventor: Allen Radin , Jennifer D. Hamilton , Leda Mannent
- Applicant: REGENERON PHARMACEUTICALS, INC. , Sanofi Biotechnology
- Applicant Address: US NY Tarrytown; FR Paris
- Assignee: REGENERON PHARMACEUTICALS, INC.,Sanofi Biotechnology
- Current Assignee: REGENERON PHARMACEUTICALS, INC.,Sanofi Biotechnology
- Current Assignee Address: US NY Tarrytown; FR Paris
- Agency: Merchant & Gould, P.C.
- Priority: EP18305252 20180308
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; C07K16/24 ; A61P1/00 ; C07K16/46 ; A61K31/56 ; A61K45/06 ; A61K39/00
Abstract:
The present invention provides methods for treating, preventing or reducing the severity of active eosinophilic esophagitis. In certain embodiments, the present invention provides methods of increasing esophageal distensibility. The methods of the present invention comprise administering to a subject in need thereof a therapeutic composition comprising an interleukin-4/interleukin-13 (IL-4/IL-13) pathway inhibitor such as an anti-IL-4R antibody.
Public/Granted literature
- US20190040126A1 METHODS FOR TREATING ACTIVE EOSINOPHILIC ESOPHAGITIS Public/Granted day:2019-02-07
Information query
